#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3396589	F	Antifungal activity against Histoplasma capsulatum G217B ATCC 26032 assessed as inhibition of visible growth after 5 days	Histoplasma capsulatum G217B	67	ALA3393037	assay format	Scientific Literature
2.	ALA3396590	F	Antifungal activity against Cryptococcus neoformans MATalpha serotype A strain H99 assessed as inhibition of visible growth after 5 days	Cryptococcus neoformans	65	ALA3393037	organism-based format	Scientific Literature
3.	ALA3396591	A	Cytotoxicity against human HepG2 cells after 72 hrs by crystal violet staining method	Homo sapiens	55	ALA3393037	cell-based format	Scientific Literature
4.	ALA3396592	U	Selectivity index, ratio of MIC50 for Histoplasma capsulatum strain G217B ATCC 26032 to MIC50 for human HepG2 cells		53	ALA3393037	cell-based format	Scientific Literature
5.	ALA3396593	A	Cytotoxicity against mouse P388D1 HepG2 cells after 48 hrs by crystal violet staining method	Mus musculus	1	ALA3393037	cell-based format	Scientific Literature
6.	ALA4222852	F	Antifungal activity against Histoplasma capsulatum G217B ATCC 26032 at pH 7 measured over 5 days	Histoplasma capsulatum	35	ALA4219175	organism-based format	Scientific Literature
7.	ALA4222853	F	Antifungal activity against wild type fluconazole-sensitive Cryptococcus neoformans serotype A H99 at pH 7 measured over 4 days	Cryptococcus neoformans	36	ALA4219175	organism-based format	Scientific Literature
8.	ALA4222854	A	Cytotoxicity against mouse P388D1 cells assessed as reduction in cell viability after 72 hrs by resazurin-based fluorescence assay	Mus musculus	35	ALA4219175	cell-based format	Scientific Literature
9.	ALA4222855	T	Therapeutic index, ratio of IC50 for mouse P388D1 cells to IC50 for Histoplasma capsulatum G217B ATCC 26032		35	ALA4219175	assay format	Scientific Literature
10.	ALA4222856	T	Therapeutic index, ratio of IC50 for mouse P388D1 cells to IC50 for wild type Cryptococcus neoformans serotype A H99		35	ALA4219175	assay format	Scientific Literature
11.	ALA4222857	F	Antifungal activity against wild-type fluconazole-sensitive Cryptococcus neoformans serotype D B3501 measured over 4 days	Cryptococcus neoformans	7	ALA4219175	organism-based format	Scientific Literature
12.	ALA4222858	F	Antifungal activity against fluconazole-resistant Cryptococcus neoformans serotype A TES9 harboring erg11 mutant measured over 4 days	Cryptococcus neoformans	7	ALA4219175	organism-based format	Scientific Literature
13.	ALA4222859	F	Antifungal activity against fluconazole-resistant Cryptococcus neoformans serotype A MRL862 harboring erg11 mutant measured over 4 days	Cryptococcus neoformans	7	ALA4219175	organism-based format	Scientific Literature
14.	ALA4222860	F	Antifungal activity against RFP expressing Histoplasma capsulatum infected in LacZ-expressing mouse P388D1 cells incubated for 6 days measured daily by fluorescence assay	Histoplasma capsulatum	4	ALA4219175	organism-based format	Scientific Literature
15.	ALA4222861	P	Aqueous solubility of the compound at pH 5		9	ALA4219175	small-molecule physicochemical format	Scientific Literature
16.	ALA4222862	P	Aqueous solubility of the compound at pH 7		9	ALA4219175	small-molecule physicochemical format	Scientific Literature
17.	ALA4222863	P	Ratio of aqueous solubility at pH 5 to aqueous solubility at pH 7		9	ALA4219175	small-molecule physicochemical format	Scientific Literature
18.	ALA4222864	F	Antifungal activity against Histoplasma capsulatum G217B ATCC 26032 at pH 5 measured over 5 days	Histoplasma capsulatum	9	ALA4219175	organism-based format	Scientific Literature
19.	ALA4222865	F	Antifungal activity against wild type fluconazole-sensitive Cryptococcus neoformans serotype A H99 at pH 5 measured over 4 days	Cryptococcus neoformans	9	ALA4219175	organism-based format	Scientific Literature
20.	ALA4222866	F	Fungistatic activity against Histoplasma capsulatum OSU76 after 2 to 24 hrs by colony forming assay	Histoplasma capsulatum	1	ALA4219175	organism-based format	Scientific Literature